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Background: Local pulmonary and systemic infections can lead to acute lung injury (ALI). The resulting lung
damage can evoke lung failure and multiple organ dysfunction associated with increased mortality. Hydrogen
sulfide (H2S) appears to represent a new therapeutic approach to ALI. The gas has been shown to mediate potent
anti-inflammatory and organ protective effects in vivo. This study was designed to define its potentially protective
role in sepsis-induced lung injury.
Methods: C57BL/6 N mice received lipopolysaccharide (LPS) intranasally in the absence or presence of 80 parts per
million H2S. After 6 h, acute lung injury was determined by comparative histology. Bronchoalveolar lavage (BAL)
fluid was analyzed for total protein content and differential cell counting. BAL and serum were further analyzed for
interleukin-1β, macrophage inflammatory protein-2, and/or myeloperoxidase glycoprotein levels by enzyme-linked
immunosorbent assays. Differences between groups were analyzed by one way analysis of variance.
Results: Histological analysis revealed that LPS instillation led to increased alveolar wall thickening, cellular
infiltration, and to an elevated ALI score. In the presence of H2S these changes were not observed despite LPS
treatment. Moreover, neutrophil influx, and pro-inflammatory cytokine release were enhanced in BAL fluid of
LPS-treated mice, but comparable to control levels in H2S treated mice. In addition, myeloperoxidase levels were
increased in serum after LPS challenge and this was prevented by H2S inhalation.
Conclusion: Inhalation of hydrogen sulfide protects against LPS-induced acute lung injury by attenuating
pro-inflammatory responses.
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Acute lung injury (ALI), and the acute respiratory distress
syndrome (ARDS), are two major challenges in clinical
practice and both are responsible for high rates of morbid-
ity and mortality amongst intensive care patients [1-3]. A
variety of stimuli can initiate ALI, such as mechanical ven-
tilation, hyperoxia, ischemia/reperfusion, transfusion, or
polytrauma [3]. Sepsis reflects one of the most important
causes of ALI [4]. The underlying strong inflammatory re-
sponse in sepsis-induced ALI is characterized by the trans-
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release of numerous pro-inflammatory cytokines, e.g.,
interleukin-1β (IL-1β) and macrophage inflammatory
protein-2 (MIP-2). As a consequence of the inflammatory
process, alveolar structures change, endothelial and alveo-
lar permeability increase and alveolar fluid clearance
decreases, thus critically impairing lung function [5]. Cur-
rently available treatment options have failed to signifi-
cantly decrease sepsis related mortality. Therefore,
alternative strategies are urgently needed to improve sup-
portive care.
In this respect, hydrogen sulfide (H2S) has come to be a
focus of interest. H2S belongs to the group of gaseous
transmitters, along with nitric oxide and carbon monoxide.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mals in low micromolar extracellular concentrations. En-
dogenous H2S has been shown to be involved in a series
of physiological processes, e.g., inflammation, vasodilata-
tion, neuromodulation, pain perception, as well as in
organ protective pathways (reviewed in [6]). Moreover, ex-
ogenous application of gaseous H2S and H2S donors in
different animal disease models like ventilator-induced
lung injury [7], ischemia/reperfusion injury [8], or oleic
acid-induced ALI [9,10], succeeded in exerting organ-
protective effects. The underlying mechanism may be
explained by the ability of H2S to inhibit the activation
and transmigration of neutrophil cells and to attenuate
the release of pro-inflammatory cytokines.
The aims of the present study were to mimic sepsis-
induced ALI by intranasal administration of the endotoxin
lipopolysaccharide (LPS) and to examine the role of con-
tinuously inhaled H2S in this injury model.
Methods
Animals and experimental setting
All animal experiments were performed in accordance
with the guidelines of the local animal care commission
(Ethics Committee University of Freiburg, Freiburg, Ger-
many, permission No. G-07/25) and in conformance with
the journals’ requirements for human and animal trials.
C57BL/6 N mice weighing 22.4 g (± 0.3 g) were random-
ly assigned into four experimental groups: (1) intranasal
(i.n.) application of endotoxin-free phosphate buffered sa-
line (70 μl) + spontaneous breathing of room air (PBS+ air),
(2) PBS treatment+ spontaneous breathing of air supple-
mented with 80 parts per million (ppm) hydrogen sulfide
(H2S, Air Liquide, Kornwestheim, Germany) (PBS+H2S),
(3) i.n. application of lipopolysaccharide (70 μl dissolved in
PBS, LPS; 0,25 ng E.coli 055:B5; Sigma-Aldrich Chemie
GmbH, Munich, Germany) + spontaneous breathing of air
(LPS+ air), (4) LPS treatment + spontaneous inhalation of
80 ppm H2S (LPS+H2S). Spontaneous breathing of the
respective gas mixture started 1 h prior to PBS or LPS in-
stillation. Instillation of PBS or LPS was conducted under
short isoflurane anesthesia. Afterwards, mice were again
placed in a sealed plexiglass chamber and subjected to ei-
ther breathe room air or H2S for another 6 h. H2S concen-
tration was continuously monitored using a portable gas
monitor (MX6 iBrid, Industrial Scientific Corporation,
Oakdale, PA).
Tissue sampling and bronchoalveolar lavage
At the end of each experiment all mice were sacrificed by
an intraperitoneal, overdosed injection of ketamine
(180 mg/kg) and acepromazine (1.8 mg/kg) and additional
bleeding. Bronchoalveolar lavage fluid, lung tissue sam-
ples, and blood samples were gained and analyzed as
described recently [11].Cytokine measurements
BAL aliquots were analyzed using interleukin-1β (IL-1β)
and macrophage inflammatory protein-2 (MIP-2) ELISA
kits (R&D Systems GmbH, Wiesbaden, Germany) accord-
ing to the manufacturers’ instructions. Serum samples
were tested using ELISA kits for myeloperoxidase (MPO)
glycoprotein (HK210 ELISA, Hycult biotech GmbH, Beu-
telsbach, Germany) and IL-1β according to the manufac-
turers’ instructions.
Histological examination
The left lung was prepared, conserved, and cut into 12 μm
thick cryosections for hematoxylin and eosin (H+E) stain-
ing as previously described [11]. From each lung, four rep-
resentative photos were taken (magnification x200). Five
high power fields (HPF) were randomly assigned to each
photo. Subsequently, alveolar wall thickness and cellular
infiltration were analyzed by Axiovision software
(AxioVS40LE, Zeiss, Jena, Germany). For each HPF, the
degree of lung damage was determined using a modified
ALI score as described earlier [11]: In brief, (a) thickness
of the alveolar walls, (b) infiltration or aggregation of in-
flammatory cells, and (c) hemorrhage were rated in a
blinded fashion. Each item was graded according to the
following point scale: 0: minimal damage, 1: mild dam-
age, 2: moderate damage, 3: severe damage, 4: maximal
damage. The degree of ALI was assessed by the sum of
scores for each HPF, ranging from 0 to 12. The average of
the sum of each field score per lung was compared among
groups.
Statistical analysis
Experiments were performed with 6–8 mice per group.
Group size was defined on the basis of expected neutro-
phil cell numbers in BAL fluid by power calculations prior
to the study. Graphs represent means± standard error of
means (SEM). Data were further analyzed for normal vari-
ation prior to one way analysis of variance (ANOVA), fol-
lowed by the Student-Newman-Keuls posthoc test. In
cases of a failed normality test, Kruskal-Wallis ANOVA
on Ranks was performed followed by Dunn`s posthoc test.
P< 0.05 was considered significant.
Results and discussion
In this study, we clearly demonstrate, that inhalation of
H2S in low dose prevents the development of acute lung
injury. Furthermore, we show that H2S treatment substan-
tially reduces local as well as systemic inflammation.
Hydrogen sulfide prevents lung damage in
LPS-induced ALI
In the presented model of pulmonary sepsis H+E staining
of lung cryosections showed that as compared to control
conditions (PBS+air, PBS+H2S, Figure 1A+B, respectively),
Figure 1 Effect of LPS and hydrogen sulfide inhalation on lung
architecture. As controls, mice received phosphate buffered saline
(PBS, intranasally) and were kept in room air (PBS + air, A) or in
80 ppm H2S (PBS +H2S, B) for 6 h (plus 1 h pretreatment).
LPS-treated mice (LPS treatment, i.n.) were either kept in room air
(LPS + air, C) or in 80 ppm H2S (LPS +H2S, D) for 6 h (plus 1 h
pretreatment). Sections from the left lung lobe were stained with
hematoxylin and eosin. Representative pictures are shown for each
experimental group (magnification = 200X).
Faller et al. Medical Gas Research 2012, 2:26 Page 3 of 6
http://www.medicalgasresearch.com/content/2/1/26LPS treatment clearly stimulated the formation of lung
edema and the influx of immune-competent cells (LPS+
air, Figure 1C). In sharp contrast, exposure to 80 ppm
H2S markedly reduced LPS-induced lung damage (LPS+
H2S, Figure 1D), reflected by decreased edema formation
and cellular infiltration into the lung tissue. These findings















































Figure 2 Effect of LPS and hydrogen sulfide inhalation on lung dama
(PBS, intranasally) and were kept in room air or in 80 ppm H2S for 6 h (plus
kept in room air or in 80 ppm H2S for 6 h (plus 1 h pretreatment). Sections
High power fields were randomly assigned to measure alveolar wall thickn
acute lung injury (ALI) score (C). Data represent means ± SEM for n= 7-8/gr
(C; Student-Newman-Keuls posthoc test), *P< 0.05 vs. PBS + air group; #P< 0prevented alveolar wall thickening (Figure 2A) and cellular
infiltration (Figure 2B), that was otherwise observed in
LPS-treated animals kept in room air. In addition, a re-
duction of lung damage to control levels by H2S inhalation
was also detected by rating an overall ALI score
(Figure 2C), strongly suggesting a lung-protective role for
H2S inhalation in LPS-induced ALI.
These results add important information to the role of
exogenous H2S in sepsis. Conflicting data exist in models
of cecal ligation and puncture demonstrating aggravation
[12-20] as well as substantial reduction of the resulting
lung injury in response to application of H2S donors
[21,22]. It is likely that the route of administration, dosage,
timing, and the purity of H2S donors may be accountable
for the inconsistent data. This study is the first to show
that inhalation of H2S clearly prevents lung damage due
to local LPS-induced injury, underlining the therapeutic
potential of this gas under septic conditions. Our findings
are further supported by a recent publication by Tokuda
et al. [23]. Here, in contrast to our study, LPS was applied
systemically. The study found inhalation of 80 ppm H2S
substantially increased survival. Although the authors did
not analyze histopathological changes in the lung, the data
suggest an organ-protective effect of H2S inhalation.
Moreover, we have shown recently that inhalation of H2S
in low dosage (80 ppm) ameliorated lung pathology in
ventilator-induced lung injury [7]. In a related model,
Francis et al. demonstrated, that inhalation of 60 ppm was
sufficient to exert a series of lung protective effects [24].
These data suggest that application of lower concentra-
tions as we used can achieve lung protection. Although
we did not detect any toxic side effects of H2S inhalation
in our model (data not shown), future studies in this dir-






















ge. As controls, mice received phosphate buffered saline
1 h pretreatment). LPS-treated mice (LPS treatment, i.n.) were either
from the left lung lobe were stained with hematoxylin and eosin.
ess (A), to count total infiltrate numbers (B), and to calculate an
oup. ANOVA on Ranks (A+B, Dunn`s posthoc test) and ANOVA
.05 vs. PBS +H2S group;
}P< 0.05 vs. LPS +H2S group.
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of the inflammatory response
We next investigated whether the observed H2S-mediated
lung-protection was attributed to inhibition of LPS-
induced inflammation. The development of lung damage
in pulmonary sepsis is known to be critically dependent
on the initiation of an inflammatory response, mainly
characterized by neutrophil transmigration and activation
and pro-inflammatory cytokine release [21,25]. Neutrophil
sequestration into the bronchoalveolar space was mark-
edly increased by LPS application as compared to the con-
trol (Figure 3A). H2S administration in LPS treated mice
substantially reduced neutrophil numbers to control
levels. Our data are in line with recent publications, where
pulmonary neutrophil activity was found to be largely
decreased in mice or rats, that had been protected from
LPS-induced systemic inflammation both by inhaled H2S
[23] as well as by application of the slowly releasing H2S
donors S-diclofenac and GYY4137 [25,26]. The findings of
these trials clearly support the notion that exogenous H2S
can inhibit pro-inflammatory processes. In combination
with neutrophil transmigration, the release of pro-
inflammatory cytokines, e.g., IL-1β and MIP-2, is known
to aggravate lung injury [21,25]. In our study, quantitative
analysis of IL-1β in the BAL revealed that it was nearly ab-
sent in both control groups (PBS+ air and PBS+H2S),
whereas LPS instillation alone led to a vast increase of IL-
1β readings (Figure 3B). In sharp contrast, H2S inhalation
reduced IL-1β to control levels. Likewise, LPS treatment
increased MIP-2 protein that was partially prevented by
H2S (Figure 3C). The attenuation of neutrophil transmi-
gration and pro-inflammatory cytokine release by admin-





































Figure 3 Effect of LPS and hydrogen sulfide inhalation on lung inflam
intranasally) and were kept in room air or in 80 ppm H2S for 6 h (plus 1 h
room air or in 80 ppm H2S for 6 h (plus 1 h pretreatment). Bronchoalveolar
neutrophils (A) was determined by cytospin analysis, and the amount of IL
means ± SEM, n= 8/group. ANOVA on Ranks (Dunn`s posthoc test), *P< 0.0
}P< 0.05 vs. LPS +H2S group.ALI, e.g., ventilator-induced lung injury [7], oleic acid-
induced lung injury [9,10], caerulein-induced acute pan-
creatitis [27], or myocardial ischemia/reperfusion injury
[28], strongly supporting our findings that gaseous H2S
substantially inhibits pulmonary inflammation and thereby
limits LPS-induced lung damage. Future studies using dif-
ferent ALI models might discover the regulatory role of
H2S in each single aspect of human ALI / ARDS in order
to define H2S` therapeutic potential.
We finally questioned whether intranasal application
of LPS would also induce systemic inflammation and
whether H2S would exert any systemic effects. As a
marker for neutrophil activity we determined the con-
centration of the MPO glycoprotein in serum [23,26].
In the present study, LPS treatment clearly increased
serum MPO release. H2S inhalation tended to reduce
MPO levels, irrespective of the mode of additional
PBS- or LPS-treatment (Figure 4A). Similar results
were obtained by analyzing serum IL-1β levels
(Figure 4B). Our findings compliment the results of
two previous studies, where LPS-induced systemic in-
flammation (e.g., plasma nitrite/nitrate levels, pro-
inflammatory cytokine release) was also clearly pre-
vented by H2S inhalation [23,29]. However, on the
basis of our results, we cannot clearly decipher,
whether i.n. LPS directly induced a systemic inflam-
mation or whether the inflammatory response
observed resulted from lung injury. Therefore two
scenarios concerning the role of H2S appear possible:
(1) H2S inhalation may directly inhibit lung and sys-
temic inflammation, or (2) H2S inhalation may pri-
marily inhibit lung inflammatory responses, secondary
























mation. As controls, mice received phosphate buffered saline (PBS,
pretreatment). LPS-treated mice (LPS treatment, i.n.) were either kept in
lavage was performed in the right lung. The relative amount of
-1β (B) and MIP-2 (C) was determined by ELISA. Graphs represent







































Figure 4 Effect of LPS and hydrogen sulfide inhalation on
systemic inflammation. As controls, mice received phosphate
buffered saline (PBS, intranasally) and were kept in room air or in
80 ppm H2S for 6 h (plus 1 h pretreatment). LPS-treated mice
(LPS treatment, i.n.) were either kept in room air or in 80 ppm H2S
for 6 h (plus 1 h pretreatment). Blood samples were withdrawn by
intracardiac punctation. Myeloperoxidase (MPO, A) and IL-1β (B)
contents were quantified by ELISA in serum. Graphs represent
means ± SEM, n= 6-8/group. ANOVA on Ranks (Dunn`s posthoc test),
#P< 0.05 vs. PBS +H2S group.
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inhibit both local as well as systemic inflammatory
responses to septic insults.
Conclusions
In our model, inhalation of hydrogen sulfide substantially
reduced LPS-induced acute lung injury. The observed pro-
tection appears to be mediated by the anti-inflammatory
effects of H2S, i.e., inhibition of neutrophil transmigration
and pro-inflammatory cytokine release. Therefore, H2S
application displays organ protective properties.
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